Published in JAMA on June 06, 2007
The association between residency training and internists' ability to practice conservatively. JAMA Intern Med (2014) 3.92
Systematic review: Effects, design choices, and context of pay-for-performance in health care. BMC Health Serv Res (2010) 2.70
P4P4P: an agenda for research on pay-for-performance for patients. Health Aff (Millwood) (2009) 2.49
CMS reimbursement reform and the incidence of hospital-acquired pulmonary embolism or deep vein thrombosis. J Gen Intern Med (2014) 2.30
Measuring the report card: the validity of pay-for-performance metrics in orthopedic surgery. Health Aff (Millwood) (2009) 2.26
Effects of the Premier Hospital Quality Incentive Demonstration on Medicare patient mortality and cost. Health Serv Res (2009) 1.94
Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction. J Am Coll Cardiol (2013) 1.72
Process of care performance measures and long-term outcomes in patients hospitalized with heart failure. Med Care (2010) 1.62
Association between the Value-Based Purchasing pay for performance program and patient mortality in US hospitals: observational study. BMJ (2016) 1.44
Patient opinions regarding 'pay for performance for patients'. J Gen Intern Med (2008) 1.38
Impact of public reporting on unreported quality of care. Health Serv Res (2008) 1.35
Key issues in the design of pay for performance programs. Eur J Health Econ (2011) 1.26
Has pay-for-performance decreased access for minority patients? Health Serv Res (2009) 1.25
Unmet need for mental health care in schizophrenia: an overview of literature and new data from a first-admission study. Schizophr Bull (2009) 1.20
Randomized trial of lottery-based incentives to improve warfarin adherence. Am Heart J (2012) 1.19
The effect of performance-based financial incentives on improving patient care experiences: a statewide evaluation. J Gen Intern Med (2009) 1.18
The effect of the MassHealth hospital pay-for-performance program on quality. Health Serv Res (2011) 1.16
Pay-for-performance in nursing homes. Health Care Financ Rev (2009) 1.11
Does delayed measurement affect patient reports of provider performance? Implications for performance measurement of medical assistance with tobacco cessation: a Dental PBRN study. BMC Health Serv Res (2008) 1.04
The impact of performance incentives on child health outcomes: results from a cluster randomized controlled trial in the Philippines. Health Policy Plan (2013) 1.04
Using the lessons of behavioral economics to design more effective pay-for-performance programs. Am J Manag Care (2010) 1.01
One-year mortality after a first visit to a cardiology outpatient clinic: a useful performance indicator? Neth Heart J (2009) 0.99
When there is no doctor: reasons for the disappearance of primary care physicians in the US during the early 21st century. Soc Sci Med (2008) 0.98
Measuring quality in health care and its implications for pay-for-performance initiatives. Hand Clin (2009) 0.97
Factors related to clinical quality improvement for small practices using an EHR. Health Serv Res (2014) 0.97
Do cardiology quality measures actually improve patient outcomes? J Am Heart Assoc (2014) 0.95
The impact of hospital pay-for-performance on hospital and Medicare costs. Health Serv Res (2012) 0.94
Do hospitals alter patient care effort allocations under pay-for-performance? Health Serv Res (2010) 0.92
Does pay-for-performance improve surgical outcomes? An evaluation of phase 2 of the Premier Hospital Quality Incentive Demonstration. Ann Surg (2014) 0.91
Rewarding healthy behaviors--pay patients for performance. Ann Fam Med (2012) 0.90
The early effects of Medicare's mandatory hospital pay-for-performance program. Health Serv Res (2014) 0.90
Reasons for Non-use of Proven Interventions for Hospital Inpatients: Pharmacists' Perspectives. Can J Hosp Pharm (2009) 0.87
Perceived impact of the Medicare policy to adjust payment for health care-associated infections. Am J Infect Control (2012) 0.87
A pediatric-focused review of the performance incentive literature. Curr Opin Pediatr (2007) 0.86
Measuring Success in Health Care Value-Based Purchasing Programs: Findings from an Environmental Scan, Literature Review, and Expert Panel Discussions. Rand Health Q (2014) 0.81
Two-year impact of the alternative quality contract on pediatric health care quality and spending. Pediatrics (2013) 0.81
Use of prolonged travel to improve pediatric risk-adjustment models. Health Serv Res (2008) 0.81
Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform. Am J Kidney Dis (2016) 0.81
Relationship between organizational factors and performance among pay-for-performance hospitals. J Gen Intern Med (2009) 0.80
Effects of Physician-Targeted Pay-for-Performance on Use of Spontaneous Breathing Trials in Mechanically Ventilated Patients. Am J Respir Crit Care Med (2016) 0.80
Insights into temporal patterns of hospital patient safety from routinely collected electronic data. Health Inf Sci Syst (2015) 0.79
Effect of the Pay-for-Performance Program for Breast Cancer Care in Taiwan. J Oncol Pract (2011) 0.79
Pay-for-performance in a community substance abuse clinic. J Subst Abuse Treat (2011) 0.79
Pay-for-Performance Initiatives: Modest Benefits for Improving Healthcare Quality. Am Health Drug Benefits (2010) 0.79
Adding A Spending Metric To Medicare's Value-Based Purchasing Program Rewarded Low-Quality Hospitals. Health Aff (Millwood) (2016) 0.78
The Effects of Antipsychotic Quality Reporting on Antipsychotic and Psychoactive Medication Use. Health Serv Res (2015) 0.78
Impact of creating a pay for quality improvement (P4QI) incentive program on healthcare disparity: leveraging HIT in rural hospitals and small physician offices. Perspect Health Inf Manag (2008) 0.77
Patient-care time allocation by nurse practitioners and physician assistants in the intensive care unit. Crit Care (2012) 0.77
Designing a model health care system. Am J Public Health (2007) 0.77
Strategies that promote high quality care in Indonesia. Health Policy (2008) 0.77
Value-driven health care: the purchasers' perspective. J Am Coll Radiol (2008) 0.75
Pay for performance in myocardial infarction: are we reaping the rewards? Nat Clin Pract Cardiovasc Med (2007) 0.75
Recent hospitalization for non-coronary events and use of preventive medications for coronary artery disease: an observational cohort study. BMC Cardiovasc Disord (2011) 0.75
The benefits of moving quality to a national level. Am Heart J (2008) 0.75
Health and life insurance as an alternative to malpractice tort law. BMC Health Serv Res (2010) 0.75
Current State of Value-Based Purchasing Programs. Circulation (2016) 0.75
Quality Improvement for Cardiovascular Disease Care in Low- and Middle-Income Countries: A Systematic Review. PLoS One (2016) 0.75
Incentives to change: effects of performance-based financing on health workers in Zambia. Hum Resour Health (2017) 0.75
Physician attitudes toward participating in a financial incentive program for LDL reduction are associated with patient outcomes. Healthc (Amst) (2016) 0.75
Interdisciplinary strategies for arrhythmia program development: measuring quality, performance, and outcomes. J Interv Card Electrophysiol (2011) 0.75
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA (2013) 12.37
Universal definition of myocardial infarction. Circulation (2007) 11.69
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med (2006) 7.54
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Prevalence of conventional risk factors in patients with coronary heart disease. JAMA (2003) 6.84
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J (2007) 6.51
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation (2011) 6.36
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA (2006) 5.78
One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA (2007) 5.61
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Bivalirudin for patients with acute coronary syndromes. N Engl J Med (2006) 5.49
Medication adherence: its importance in cardiovascular outcomes. Circulation (2009) 5.30
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med (2009) 5.19
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation (2013) 5.02
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA (2006) 5.00
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA (2012) 4.92
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol (2010) 4.50
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39
Appropriateness of percutaneous coronary intervention. JAMA (2011) 4.33
Compliance with results reporting at ClinicalTrials.gov. N Engl J Med (2015) 4.17
Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA (2010) 4.13
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg (2009) 4.10
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA (2008) 4.06
Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation (2006) 3.96
Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy. Circulation (2010) 3.95
Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg (2002) 3.86
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med (2005) 3.83
Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med (2002) 3.77
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA (2005) 3.72
Conversion of cardiovascular conference abstracts to publications. Circulation (2012) 3.71
Procedural volume as a marker of quality for CABG surgery. JAMA (2004) 3.70
Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med (2008) 3.68
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Arch Intern Med (2008) 3.68
Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA (2012) 3.66
Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med (2004) 3.64
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg (2014) 3.59
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol (2009) 3.54
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45
Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA (2004) 3.45
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA (2011) 3.44
Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J (2008) 3.40
Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation (2006) 3.38